| Rincon Resources Limited (RCR) ORDINARY FULLY PAID |
Materials |
$7 |
Change of Director's Interest Notice's
|
28 Aug 2025 6:49PM |
$0.013 |
$0.014 |
risen by
7.69%
|
|
| Bellevue Gold Limited (BGL) ORDINARY FULLY PAID |
Materials |
$1,983 |
Notification regarding unquoted securities - BGL
|
28 Aug 2025 6:46PM |
$0.870 |
$1.330 |
risen by
52.87%
|
|
| Experience Co Limited (EXP) ORDINARY FULLY PAID |
Consumer Discretionary |
$58 |
Appendix 4G and Corporate Governance Statement
|
28 Aug 2025 6:46PM |
$0.130 |
$0.077 |
fallen by
40.77%
|
|
| Black Cat Syndicate Limited (BC8) ORDINARY FULLY PAID |
Materials |
$700 |
Application for quotation of securities - BC8
|
28 Aug 2025 6:40PM |
$0.875 |
$0.960 |
risen by
9.71%
|
|
| Black Cat Syndicate Limited (BC8) ORDINARY FULLY PAID |
Materials |
$700 |
Exercise of Employee Performance Rights
|
28 Aug 2025 6:39PM |
$0.875 |
$0.960 |
risen by
9.71%
|
|
| Experience Co Limited (EXP) ORDINARY FULLY PAID |
Consumer Discretionary |
$58 |
FY25 Results Announcement
|
28 Aug 2025 6:38PM |
$0.130 |
$0.077 |
fallen by
40.77%
|
|
EXP - Price-sensitive ASX Announcement
Full Release
Key Points
- EXP reported on its operational and financial performance for FY25.
- The announcement covered revenue, EBITDA, and profit or loss figures for the period.
- Strategic initiatives and investments aimed at supporting long-term growth were detailed.
- The company provided updates on its adventure tourism portfolio and market recovery.
- Management discussed ongoing efforts to enhance customer experience and operational efficiency.
- Risks and market conditions impacting business performance were highlighted.
- Forward-looking statements about trading conditions and strategic priorities for FY25 were included.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Clean TeQ Water Limited (CNQ) ORDINARY FULLY PAID |
Industrials |
$40 |
Appendix 4G and Corporate Governance Statement
|
28 Aug 2025 6:38PM |
$0.250 |
$0.455 |
risen by
82%
|
|
| BlinkLab Limited (BB1) ORDINARY FULLY PAID |
Health Care |
$99 |
Appendix 4G & Corporate Governance Statement
|
28 Aug 2025 6:37PM |
$0.540 |
$0.650 |
risen by
20.37%
|
|
| Clean TeQ Water Limited (CNQ) ORDINARY FULLY PAID |
Industrials |
$40 |
Appendix 4E and Full Year Statutory Accounts
|
28 Aug 2025 6:36PM |
$0.250 |
$0.455 |
risen by
82%
|
|
CNQ - Price-sensitive ASX Announcement
Full Release
Key Points
- Clean TeQ Water Limited reported a 121% increase in revenue for FY23, reaching $19.6 million.
- The net loss after tax was reduced to $1.2 million, down from $13.6 million in FY22.
- Growth was driven by project deliveries and technology sales expansion.
- The company maintained a strong cash position and continued investments in research and development.
- No dividends were paid or proposed for the period.
- The company is diversifying through both water treatment solutions and new battery materials.
- A robust pipeline of projects and strategic partnerships was noted as key to future growth.
- The company expects continued momentum and improved financial results in the coming year.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Experience Co Limited (EXP) ORDINARY FULLY PAID |
Consumer Discretionary |
$58 |
FY25 Results Presentation
|
28 Aug 2025 6:35PM |
$0.130 |
$0.077 |
fallen by
40.77%
|
|
EXP - Price-sensitive ASX Announcement
Full Release
Key Points
- EXP achieved a return to profitability and improved financial performance in FY25.
- Strong growth in skydiving and adventure experiences, supported by a rebound in tourism.
- Focused on business transformation, including brand and digital platform improvements.
- Successfully controlled costs and generated robust cash flow.
- Strategic investments planned in high-margin products and targeted marketing.
- Enhanced customer experiences and product innovation remain top priorities.
- Outlined risks and opportunities, with a positive outlook for future performance.
- Strengthened market position as a leading adventure tourism operator in Australia and New Zealand.
- Board and management remain committed to driving sustainable growth and shareholder value.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Liontown Limited (LTR) ORDINARY FULLY PAID |
Materials |
$5,420 |
Appendix 3Y - Jennifer Morris
|
28 Aug 2025 6:34PM |
$0.885 |
$1.705 |
risen by
92.66%
|
|
| AusGold Limited (AUC) ORDINARY FULLY PAID |
Materials |
$466 |
Change of Director's Interest Notice
|
28 Aug 2025 6:33PM |
$0.810 |
$0.850 |
risen by
4.94%
|
|
| Experience Co Limited (EXP) ORDINARY FULLY PAID |
Consumer Discretionary |
$58 |
Dividend/Distribution - EXP
|
28 Aug 2025 6:32PM |
$0.130 |
$0.077 |
fallen by
40.77%
|
|
| Urbanise.Com Limited (UBN) ORDINARY FULLY PAID |
Information Technology |
$51 |
Change in substantial holding
|
28 Aug 2025 6:28PM |
$0.780 |
$0.650 |
fallen by
16.67%
|
|
| HeraMED Limited (HMD) ORDINARY FULLY PAID |
Health Care |
$50 |
Appendix 4D and Half Year Report
|
28 Aug 2025 6:25PM |
$0.033 |
$0.043 |
risen by
30.30%
|
|
HMD - Price-sensitive ASX Announcement
Full Release
Key Points
- HeraMED Limited released its Appendix 4D and Half Year Report for the period ended 31 December 2023.
- The company continues to focus on the global expansion of its digital maternity care platform, HeraCARE.
- Several pilot programs and commercial rollouts are ongoing with healthcare providers and insurers.
- Revenue for the half-year was $245,253, with a net loss of $1,697,564 after tax.
- The company made strategic investments in sales, marketing, and product development.
- No dividends were paid or declared for the period.
- The directors' report covers principal activities, review of operations, and significant changes during the year.
- Financial statements include the balance sheet, income statement, and cash flow statement for the half-year.
- The company holds sufficient cash reserves to support ongoing operations.
- Future outlook highlights continued focus on technology development and commercial partnerships in digital maternal healthcare.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Arika Resources Limited (ARI) ORDINARY FULLY PAID |
Materials |
$25 |
Cleansing Notice
|
28 Aug 2025 6:24PM |
$0.046 |
$0.020 |
fallen by
56.52%
|
|
| Cynata Therapeutics Limited (CYP) ORDINARY FULLY PAID |
Health Care |
$3 |
Appendix 4G
|
28 Aug 2025 6:24PM |
$0.200 |
$0.013 |
fallen by
93.50%
|
|
| Omnia Metals Group Limited (OM1) ORDINARY FULLY PAID |
Materials |
$7 |
Appendix 3Y x 3
|
28 Aug 2025 6:24PM |
$0.014 |
$0.018 |
risen by
28.57%
|
|
| Arika Resources Limited (ARI) ORDINARY FULLY PAID |
Materials |
$25 |
Application for quotation of securities - ARI
|
28 Aug 2025 6:23PM |
$0.046 |
$0.020 |
fallen by
56.52%
|
|
| Cynata Therapeutics Limited (CYP) ORDINARY FULLY PAID |
Health Care |
$3 |
Corporate Governance Statement
|
28 Aug 2025 6:23PM |
$0.200 |
$0.013 |
fallen by
93.50%
|
|
| BlinkLab Limited (BB1) ORDINARY FULLY PAID |
Health Care |
$99 |
2025 Annual Report & Appendix 4E
|
28 Aug 2025 6:23PM |
$0.540 |
$0.650 |
risen by
20.37%
|
|
BB1 - Price-sensitive ASX Announcement
Full Release
Key Points
- BlinkLab Limited has released its Annual Report & Appendix 4E for the year ended 31 December 2023.
- The company changed its financial year end from 30 June to 31 December as approved by shareholders at the 2023 AGM.
- The report details continued product development, pilot studies, and key milestones in advancing the commercialisation of their mobile-based neurobehavioral assessment platform.
- Significant achievements include the launch of the updated BlinkLab App, progression of clinical validation studies in Europe and the US, and partnerships with academic and commercial entities.
- Revenue for the period was modest, primarily from research and development tax incentives, with operating losses reflecting ongoing investment in product development and clinical trials.
- The company raised additional capital via a share placement and convertible note to support continued operations and growth.
- Emphasis was placed on expanding the intellectual property portfolio, securing patents, and enhancing regulatory compliance.
- Risks identified include competition, clinical trial outcomes, regulatory changes, and reliance on key personnel.
- The Board remains confident in the growth prospects and future commercialisation of BlinkLab’s technology.
- Governance, financial statements, auditor's report, and remuneration details are included, meeting compliance requirements for ASX-listed entities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Cynata Therapeutics Limited (CYP) ORDINARY FULLY PAID |
Health Care |
$3 |
Appendix 4E & Annual Report
|
28 Aug 2025 6:23PM |
$0.200 |
$0.013 |
fallen by
93.50%
|
|
CYP - Price-sensitive ASX Announcement
Full Release
Key Points
- Cynata Therapeutics Limited released its Appendix 4E and Annual Report for the year ended 30 June 2023.
- Significant progress was made in the development and clinical advancement of Cymerus™ stem cell technology.
- Positive clinical outcomes were achieved in trials, particularly with lead product candidates like CYP-001.
- Strategic partnerships and collaborations were expanded to support research and commercialization goals.
- The company reported a net loss after tax, consistent with expenses for research, development, and operations.
- Corporate governance, risk management, and remuneration frameworks were reviewed and outlined.
- Future plans focus on achieving further clinical trial milestones and progressing commercial opportunities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| AusGold Limited (AUC) ORDINARY FULLY PAID |
Materials |
$466 |
Notice under Section 708A of the Corporations Act 2001
|
28 Aug 2025 6:21PM |
$0.810 |
$0.850 |
risen by
4.94%
|
|
| Ainsworth Game Technology Limited (AGI) ORDINARY FULLY PAID |
Consumer Discretionary |
$408 |
Change in substantial holding
|
28 Aug 2025 6:21PM |
$1.000 |
$1.210 |
risen by
21%
|
|
| Brazilian Critical Minerals Limited (BCM) ORDINARY FULLY PAID |
Materials |
$108 |
Application for quotation of securities - BCM
|
28 Aug 2025 6:21PM |
$0.023 |
$0.055 |
risen by
139.13%
|
|
Call 1300 880 160
Start a chat
Schedule a call
